Substance Use Screening Tools & Resources
SBIRT Fact Sheet for Medicare and Medicaid
CMS fact sheet provides an overview of Medicare and Medicaid coverage of SBIRT services: who may perform the services, documentation requirements, billing and coding guidance, payment information, and more. (pdf)
NIDA Online/Mobile App Screening Tool
Guides clinicians through series of questions to identify risky substance use in their adult patients. Accompanying resources assist clinicians in providing patient feedback and arranging for specialty care, where necessary, using the 5 As of intervention.
NIDA Clinician's Resource Guide
Provides more detailed instructions to clinicians on how to use the tool, discuss screening results, offer brief interventions, and make necessary referrals. Also includes information on conducting biological specimen screening and locating substance abuse treatment facilities.
     
ASSIST, Version 3.0
World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) includes questionnaire for clinician, patient response card, patient feedback card, and risks of injecting card. (pdf)
APNA Position Paper: Adoption of SBIRT
2012 paper supporting the adoption of SBIRT into all clinical settings. The competencies and scope of practice of psychiatric-mental health nurses position them well to use and teach others about SBIRT.
NIDA Screening Tool: Quick Reference Guide
Designed to fit into a coat pocket, this guide provides an abbreviated, handy version of NIDA’s Drug Use Screening tool and instructions on its use. (pdf)
 
 
 
Systems-Level Implementation of Screening, Brief Intervention, and Referral to Treatment (SBIRT)
From SAMHSA, describes core elements of SBIRT programs - services implementation, challenges, barriers, cost, coding and sustainability. (pdf)
Drug & Alcohol Use Screening Tools
Gathered by the SAMHSA Center for Integrated Health Solutions, these tools are intended to encourage regular screenings in primary care and other healthcare settings in order to enable earlier identification of substance use disorders.
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction - Appendix B Assessment and Screening Instruments
A variety of  drug and alcohol assessment and screening instruments from the National Center for Biotechnology Information
 
 
 

APNA is not responsible for the content of external websites.